Compare FMC Corp (FMC) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Halozyme Therapeutics Inc. Common Stock — how do they compare? FMC Corp trades at $8.89 (market cap $1.41B), while Halozyme Therapeutics Inc. Common Stock trades at $109.88 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 8.9× FMC Corp's market cap, and FMC Corp pays a 3.52% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| FMC | HALO | |
|---|---|---|
Market Cap | $1.41B | $12.58B |
Volume | 4,507,459 | 2,179,278 |
Sector | Basic Materials | Health |
52-Week High | $30.63 | $115.22 |
52-Week Low | $8.44 | $61.63 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | $5.22B | $14.49B |
Dividend Yield | 3.52% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC trades at $8.92, down 1.22% on the day, with a bearish technical signal and negative profitability metrics including a net income margin of -84.83% and ROE of -91.47% for 2025. Recent news highlights regulatory progress with rimisoxafen in Brazil and a minority equity investment from Tessenderlo Group. Cash flow trends show volatility, with 2025 net cash flow positive at $227.20M but driven by financing activities as operating cash flow was negative.
The outlook is challenged by significant losses and high debt, though analyst consensus suggests upside with a $14.60 price target. Key risks include sustained negative margins, industry cyclicality, and execution of deleveraging plans. The stock presents a high-risk opportunity contingent on operational turnaround and debt reduction success.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
